
Highlights
The global Nucleic Acid Testing market was valued at US$ 2069.6 million in 2022 and is anticipated to reach US$ 2886.2 million by 2029, witnessing a CAGR of 5.7% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Nucleic Acid Testing is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Nucleic Acid Testing is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Nucleic Acid Testing in Hospitals is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Nucleic Acid Testing include Agilent Technologies, Danaher Corporation, Abbott Laboratories, Inc., Becton, Dickinson, Bio-Rad Laboratories, Roche, Illumina, Inc, Thermo Fisher Scientific Inc. and Merck KGaA, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Nucleic Acid Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nucleic Acid Testing.
The Nucleic Acid Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Nucleic Acid Testing market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nucleic Acid Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Agilent Technologies
Danaher Corporation
Abbott Laboratories, Inc.
Becton, Dickinson
Bio-Rad Laboratories
Roche
Illumina, Inc
Thermo Fisher Scientific Inc.
Merck KGaA
Qiagen
Segment by Type
Transcription-mediated Amplification (TMA)
Polymerase Chain Reaction (PCR)
Ligase Chain Reaction (LCR)
Whole Genome Sequencing
Segment by Application
Hospitals
Pathology Laboratories
Research Institutes
Clinics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nucleic Acid Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nucleic Acid Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Transcription-mediated Amplification (TMA)
1.2.3 Polymerase Chain Reaction (PCR)
1.2.4 Ligase Chain Reaction (LCR)
1.2.5 Whole Genome Sequencing
1.3 Market by Application
1.3.1 Global Nucleic Acid Testing Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Pathology Laboratories
1.3.4 Research Institutes
1.3.5 Clinics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nucleic Acid Testing Market Perspective (2018-2029)
2.2 Nucleic Acid Testing Growth Trends by Region
2.2.1 Global Nucleic Acid Testing Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Nucleic Acid Testing Historic Market Size by Region (2018-2023)
2.2.3 Nucleic Acid Testing Forecasted Market Size by Region (2024-2029)
2.3 Nucleic Acid Testing Market Dynamics
2.3.1 Nucleic Acid Testing Industry Trends
2.3.2 Nucleic Acid Testing Market Drivers
2.3.3 Nucleic Acid Testing Market Challenges
2.3.4 Nucleic Acid Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nucleic Acid Testing Players by Revenue
3.1.1 Global Top Nucleic Acid Testing Players by Revenue (2018-2023)
3.1.2 Global Nucleic Acid Testing Revenue Market Share by Players (2018-2023)
3.2 Global Nucleic Acid Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nucleic Acid Testing Revenue
3.4 Global Nucleic Acid Testing Market Concentration Ratio
3.4.1 Global Nucleic Acid Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nucleic Acid Testing Revenue in 2022
3.5 Nucleic Acid Testing Key Players Head office and Area Served
3.6 Key Players Nucleic Acid Testing Product Solution and Service
3.7 Date of Enter into Nucleic Acid Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nucleic Acid Testing Breakdown Data by Type
4.1 Global Nucleic Acid Testing Historic Market Size by Type (2018-2023)
4.2 Global Nucleic Acid Testing Forecasted Market Size by Type (2024-2029)
5 Nucleic Acid Testing Breakdown Data by Application
5.1 Global Nucleic Acid Testing Historic Market Size by Application (2018-2023)
5.2 Global Nucleic Acid Testing Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Nucleic Acid Testing Market Size (2018-2029)
6.2 North America Nucleic Acid Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Nucleic Acid Testing Market Size by Country (2018-2023)
6.4 North America Nucleic Acid Testing Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nucleic Acid Testing Market Size (2018-2029)
7.2 Europe Nucleic Acid Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Nucleic Acid Testing Market Size by Country (2018-2023)
7.4 Europe Nucleic Acid Testing Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nucleic Acid Testing Market Size (2018-2029)
8.2 Asia-Pacific Nucleic Acid Testing Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Nucleic Acid Testing Market Size by Region (2018-2023)
8.4 Asia-Pacific Nucleic Acid Testing Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nucleic Acid Testing Market Size (2018-2029)
9.2 Latin America Nucleic Acid Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Nucleic Acid Testing Market Size by Country (2018-2023)
9.4 Latin America Nucleic Acid Testing Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nucleic Acid Testing Market Size (2018-2029)
10.2 Middle East & Africa Nucleic Acid Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Nucleic Acid Testing Market Size by Country (2018-2023)
10.4 Middle East & Africa Nucleic Acid Testing Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Agilent Technologies
11.1.1 Agilent Technologies Company Detail
11.1.2 Agilent Technologies Business Overview
11.1.3 Agilent Technologies Nucleic Acid Testing Introduction
11.1.4 Agilent Technologies Revenue in Nucleic Acid Testing Business (2018-2023)
11.1.5 Agilent Technologies Recent Development
11.2 Danaher Corporation
11.2.1 Danaher Corporation Company Detail
11.2.2 Danaher Corporation Business Overview
11.2.3 Danaher Corporation Nucleic Acid Testing Introduction
11.2.4 Danaher Corporation Revenue in Nucleic Acid Testing Business (2018-2023)
11.2.5 Danaher Corporation Recent Development
11.3 Abbott Laboratories, Inc.
11.3.1 Abbott Laboratories, Inc. Company Detail
11.3.2 Abbott Laboratories, Inc. Business Overview
11.3.3 Abbott Laboratories, Inc. Nucleic Acid Testing Introduction
11.3.4 Abbott Laboratories, Inc. Revenue in Nucleic Acid Testing Business (2018-2023)
11.3.5 Abbott Laboratories, Inc. Recent Development
11.4 Becton, Dickinson
11.4.1 Becton, Dickinson Company Detail
11.4.2 Becton, Dickinson Business Overview
11.4.3 Becton, Dickinson Nucleic Acid Testing Introduction
11.4.4 Becton, Dickinson Revenue in Nucleic Acid Testing Business (2018-2023)
11.4.5 Becton, Dickinson Recent Development
11.5 Bio-Rad Laboratories
11.5.1 Bio-Rad Laboratories Company Detail
11.5.2 Bio-Rad Laboratories Business Overview
11.5.3 Bio-Rad Laboratories Nucleic Acid Testing Introduction
11.5.4 Bio-Rad Laboratories Revenue in Nucleic Acid Testing Business (2018-2023)
11.5.5 Bio-Rad Laboratories Recent Development
11.6 Roche
11.6.1 Roche Company Detail
11.6.2 Roche Business Overview
11.6.3 Roche Nucleic Acid Testing Introduction
11.6.4 Roche Revenue in Nucleic Acid Testing Business (2018-2023)
11.6.5 Roche Recent Development
11.7 Illumina, Inc
11.7.1 Illumina, Inc Company Detail
11.7.2 Illumina, Inc Business Overview
11.7.3 Illumina, Inc Nucleic Acid Testing Introduction
11.7.4 Illumina, Inc Revenue in Nucleic Acid Testing Business (2018-2023)
11.7.5 Illumina, Inc Recent Development
11.8 Thermo Fisher Scientific Inc.
11.8.1 Thermo Fisher Scientific Inc. Company Detail
11.8.2 Thermo Fisher Scientific Inc. Business Overview
11.8.3 Thermo Fisher Scientific Inc. Nucleic Acid Testing Introduction
11.8.4 Thermo Fisher Scientific Inc. Revenue in Nucleic Acid Testing Business (2018-2023)
11.8.5 Thermo Fisher Scientific Inc. Recent Development
11.9 Merck KGaA
11.9.1 Merck KGaA Company Detail
11.9.2 Merck KGaA Business Overview
11.9.3 Merck KGaA Nucleic Acid Testing Introduction
11.9.4 Merck KGaA Revenue in Nucleic Acid Testing Business (2018-2023)
11.9.5 Merck KGaA Recent Development
11.10 Qiagen
11.10.1 Qiagen Company Detail
11.10.2 Qiagen Business Overview
11.10.3 Qiagen Nucleic Acid Testing Introduction
11.10.4 Qiagen Revenue in Nucleic Acid Testing Business (2018-2023)
11.10.5 Qiagen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Agilent Technologies
Danaher Corporation
Abbott Laboratories, Inc.
Becton, Dickinson
Bio-Rad Laboratories
Roche
Illumina, Inc
Thermo Fisher Scientific Inc.
Merck KGaA
Qiagen
Ìý
Ìý
*If Applicable.
